1 / 1

Message Testing Study for Cholesterol Treatment

The client was facing increasing competition from generics and new products in Europe.<br>

AronaSouris
Download Presentation

Message Testing Study for Cholesterol Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Message Testing Study for Cholesterol Treatment Study Type Quantitative Research Sample Size Background Objective Research Methodology Outcome n=120 The client was facing increasing competition from generics and new products in Europe. Evaluate all existing brand message to understand appropriateness, credibility & relevance. Analyze the messages designed to support new proposition. Identify the message with most positive impact for driving prescription. The study included a mix of GPs, cardiologist, endocrinologist / dialectologist with a focus on face-to-face IDIs. The survey lasted for a duration of 60 mins. Target audience included GPs, cardiologist, endocrinologist / dialectologist Sample size was based on appropriate quota as per client instruction. Safety & efficacy: 37% physicians associated with this message. Cardiovascular risk reduction: 70% physicians confirmed that client brand reduces cardiac risk. Appropriate, credibility & relevance: Almost 90% of physicians confirmed client brand is credible compared to competition. Target Group Business Impact GPs, Cardiologist, Endocrinologist / Dialectologist Using study insights, clients designed new campaign on “cardiovascular risk spectrum.” Geography France, Germany, Italy, Netherlands, Spain, UK connect@borderlessaccess.com borderlessaccess.com

More Related